Flagship Ventures, a Cambridge, Massachusetts-based venture capital and venture creation firm focused on innovations in healthcare and sustainability, appointed Dr. Robert Berendes as a Venture Partner.
Dr. Berendes, who is co-owner and partner at a-connect, a global consulting firm and talent pool headquartered in Switzerland and was a member of the executive team at Syngenta, will provide strategic counsel and support to the Flagship team. Through board and advisory roles, he will engage with portfolio companies focused on innovations that address sustainability in the energy, water, and agriculture/nutrition sectors.
Before joining Syngenta, Dr. Berendes was a partner at McKinsey & Company, co-heading the firm’s European Chemical Practice. He started his career as a process engineer at Procter & Gamble.
Led by Dr. Noubar Afeyan, Managing Partner and Chief Executive Officer, Flagship Ventures operates through two synergistic units:
– VentureLabs™, its innovation foundry which invents and launches transformative companies, and
– Venture Capital, which finances and develops early-stage companies.
Founded in 2000, the firm manages over $900 million in capital and has founded 27 ventures while investing in another 45. The firm is active in three principal business sectors: therapeutics, health technologies and sustainability.